Search
for
Sort by
Research 511–540 of 1000+
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- Topical Application of Aprepitant Inhibits Erlotinib-induced Facial Dermatitis/Hair Loss
- Emerging Therapies for Acne Vulgaris
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Evaluating Scarring Alopecia Therapies from the Patient Perspective: Knowledge, Barriers to Care, and Treatment Satisfaction
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Refractory dermatomyositis–systemic lupus erythematosus overlap syndrome and response to tofacitinib
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
- Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
- Premature hair graying: a multifaceted phenomenon
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Migration Inhibitory Factor in Conditioned Medium from Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells Stimulates Hair Growth
- Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team